Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPK10 | P53779 | 3/20 | 0.40 |
| ▸ | MAPK9 | P45984 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | HTR3A | P46098 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23204001 | 0.91 | CYP2A6 (0.50) | CYP2A6TDP1KDM4EATML3MBTL1 | |
| SCHEMBL12109707 | 0.91 | CYP2A6 (0.48) | CYP2A6TDP1KDM4EATML3MBTL1 | |
| SCHEMBL12571944 | 0.90 | CYP2A6 (0.50) | CYP2A6TDP1KDM4EATML3MBTL1 | |
| SCHEMBL29294330 | 0.90 | CYP2A6 (0.49) | CYP2A6TDP1KDM4EATML3MBTL1 | |
| SCHEMBL22848373 | 0.89 | CYP2A6 (0.47) | CYP2A6TDP1RAB9AALDH1A1GAA | |
| SCHEMBL25968814 | 0.89 | CYP2A6 (0.47) | CYP2A6TDP1KDM4EATML3MBTL1 | |
| SCHEMBL16409623 | 0.89 | KDM4E (0.50) | KDM4EATML3MBTL1RAB9AALDH1A1 | |
| SCHEMBL16409588 | 0.89 | KDM4E (0.50) | KDM4EATML3MBTL1RAB9AALDH1A1 | |
| SCHEMBL18689461 | 0.88 | CYP2A6 (0.43) | CYP2A6TDP1KDM4EATML3MBTL1 | |
| SCHEMBL26226195 | 0.88 | KDM4E (0.44) | CYP2A6TDP1KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | US | disclosed |
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2023-11-23 | — | — | US | disclosed |
| US-20230354625-A1 | PHOTOELECTRIC CONVERSION DEVICE AND LIGHT-EMITTING AND LIGHT-RECEIVING APPARATUS | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-11-02 | — | — | US | disclosed |
| US-20230301189-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-09-21 | — | — | US | disclosed |
| US-20230301189-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-09-21 | — | — | US | disclosed |
| US-20230200227-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230200227-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-06-22 | — | — | US | disclosed |
| US-20230132153-A1 | Organic Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-04-27 | — | — | US | disclosed |
| WO-2021214348-A2 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2021-10-28 | — | — | WO | disclosed |
| US-20210159422-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-05-27 | — | — | US | disclosed |
| US-20140371825-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2014-12-18 | — | — | US | disclosed |
| US-20140371825-A1 | ORGANIC METAL COMPLEXES | UDC IRELAND LIMITED (IE) | 2014-12-18 | — | — | US | disclosed |
| US-20140358198-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20140358198-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2014-12-04 | — | — | US | disclosed |
| US-20140350642-A1 | Metal Complexes Comprising 1,2,3-Triazoles | MERCK PATENT GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| US-20140350642-A1 | Metal Complexes Comprising 1,2,3-Triazoles | MERCK PATENT GMBH (DE) | 2014-11-27 | — | — | US | disclosed |
| WO-2013174471-A1 | METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS | MERCK PATENT GMBH (DE) | 2013-11-28 | — | — | WO | disclosed |
| WO-2013107487-A1 | ORGANIC METAL COMPLEXES | MERCK PATENT GMBH (DE) | 2013-07-25 | — | — | WO | disclosed |
| WO-2013097920-A1 | METAL COMPLEXES COMPRISING 1,2,3-TRIAZOLES | MERCK PATENT GMBH (DE) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013087162-A1 | ORGANIC SENSITIZERS FOR UP-CONVERSION | MERCK PATENT GMBH (DE) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230373941-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP2E1, GPX1, ERCC1 | CYP2A6 188/4885TDP1 1010/4885KDM4E 2854/4885 |
| US-20210159422-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | ARNT, SUN2, AHR | CYP2A6 874/4885TDP1 3762/4885KDM4E 3263/4885 |
| US-20230132153-A1 | Organic Compound | CCNA1, DRD1, CYP1A1 | CYP2A6 67/4885TDP1 4114/4885KDM4E 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.